WORK Medical Plummets 32.9%: Reverse Split Triggers Liquidity Crisis as Shares Near 52-Week Low

Summary
• WORK Medical (WOK) slumps 32.9% intraday to $0.0328, a 66% discount to its 52-week high of $600
• 1-for-100 reverse stock split announced Dec 24 triggers liquidity concerns and sharp price drop
• Turnover surges 10,480% to 73.2M shares amid Nasdaq compliance maneuver
• Intraday range collapses from $0.048 high to $0.0276 low, signaling extreme volatility

WORK Medical’s dramatic 32.9% intraday plunge has sent shockwaves through the Nasdaq, driven by its impending 1-for-100 reverse stock split. The move, aimed at complying with Nasdaq’s minimum bid price rule, has triggered a liquidity crisis as shares trade near their 52-week low of $0.0276. With turnover exploding 10,480% to 73.2 million shares, the stock’s technicals and corporate action create a volatile cocktail for traders.

Reverse Stock Split Triggers Liquidity Collapse
WORK Medical’s 1-for-100 reverse stock split, effective Dec 29, has catalyzed a liquidity vacuum as shares trade at 66% of their 52-week low. The corporate action, mandated by Nasdaq Rule 5550(a)(2), consolidates 100 shares into one, artificially inflating per-share price while diluting tradable volume. Fractional shares are rounded up, further reducing market depth. This structural shift has triggered panic selling as investors scramble to exit pre-split positions, exacerbating the 32.9% intraday drop.

Technical Deterioration and Options Void: Navigating the WOK Freefall
• MACD: -1.105 (bearish divergence), Signal Line: -0.743, Histogram: -0.362 (deepening bearish momentum)
• RSI: 22.78 (oversold territory), Bollinger Bands: $0.0276 (lower band) vs. $8.42 (upper band) – extreme volatility
• 200D MA: $1.236 (price at $0.0319, 97% below), 30D MA: $3.229 (price at $0.0319, 99% below)

WORK Medical’s technicals paint a dire picture: RSI at 22.78 signals oversold conditions, but bearish momentum from MACD (-1.105) and 200D MA divergence ($1.236 vs. $0.0319) suggest further deterioration. Bollinger Bands show price at the lower bound ($0.0276), indicating potential for a rebound or continuation of the selloff. With no options liquidity, traders must rely on ETFs like XLF (financials) for indirect exposure, though WOK’s sector-specific collapse limits ETF utility. Short-term traders should monitor the 52-week low ($0.0276) as a critical support level; a break below could trigger a liquidity death spiral.

Backtest WORK Medical Stock Performance
The backtest of WOK's performance after a -33% intraday plunge from 2022 to now shows mixed results. The 3-Day win rate is 47.95%, the 10-Day win rate is 47.95%, and the 30-Day win rate is 43.27%. While the stock has experienced a maximum return of 3.95% over 33 days, the overall return has been negative, with a -0.89% return over 3 days, a 0.13% return over 10 days, and a 2.14% return over 30 days.

WOK’s Reverse Split: A Death Knell or Rebirth?
WORK Medical’s reverse stock split represents a desperate bid for Nasdaq compliance, but the 32.9% intraday plunge exposes structural fragility. With price at 0.66% of its 52-week high ($600) and 99% below its 200D MA, the stock faces existential risks. Traders should watch for a breakdown below $0.0276, which could trigger delisting. Meanwhile, Medtronic’s -0.205% move highlights sector resilience. Investors must decide: is this a short-term volatility play or a permanent impairment? The answer lies in whether WOK can regain $0.0489 (previous close) by Dec 29’s post-split open.